Ebola vaccination

The Lancet

Volumn 386, Issue 10012, 2015, Pages 2478-

  Fitzgerald, Felicity ^a,c   Yeung, Shunmay ^d   Gibb, Diana M ^b   Baion, David E ^e   Pollard, Andrew ^f  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c SAVE THE CHILDREN   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Ola During Children's Hospital   (Sierra Leone)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EBOLA VACCINE; VIRUS VECTOR;

ADENOVIRIDAE; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; HUMAN; LETTER; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; VACCINATION; VIRUS TRANSMISSION; FEMALE; HEMORRHAGIC FEVER, EBOLA; MALE;

EBOLA VACCINES; FEMALE; HEMORRHAGIC FEVER, EBOLA; HUMANS; MALE;

EID: 84960355922     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)01243-X     Document Type: Letter

References (4)

1. AM Henao-Restrepo, IM Longini, M Egger et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial Lancet 386 2015 857 866
2. WHO Ebola Response Team J Agua-Agum, A Ariyarajah et al. Ebola virus disease among children in west Africa N Engl J Med 372 2015 1274 1277
3. Ebola data and statistics http://apps.who.int/gho/data/node.ebola-sitrep.quick-downloads?lang=en 2015 (accessed Oct 8, 2015)
4. DS Chertow, C Kleine, JK Edwards, R Scaini, R Giuliani, A Sprecher Ebola virus disease in west Africa - clinical manifestations and management N Engl J Med 371 2014 2054 2057